Open AccessHepatobiliary phases in magnetic resonance imaging using liver-specific contrast for focal lesions in clinical practice
Author(s) -
Daniel Alvarenga Fernandes,
Eduardo Andreazza Dal Lago,
Felipe Aguera Oliver,
Bruna Melo Coelho Loureiro,
Daniel Lahan Martins,
Thiago José Penachim,
Ricardo Hoelz de Oliveira Barros,
José de Arimatéia Batista Araújo Filho,
Larissa Bastos Eloy da Costa,
Áurea Maria Oliveira da Silva,
Elaine Cristina de Ataíde,
Ilka de Fátima Santana Ferreira Boin,
Nelson Marcio Gomes Caserta
Publication year - 2022
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v14.i7.1459
Subject(s) - gadoxetic acid , medicine , magnetic resonance imaging , stage (stratigraphy) , radiology , clinical practice , lesion , pathology , gadolinium dtpa , paleontology , family medicine , biology
Challenging lesions, difficult to diagnose through non-invasive methods, constitute an important emotional burden for each patient regarding a still uncertain diagnosis (malignant x benign). In addition, from a therapeutic and prognostic point of view, delay in a definitive diagnosis can lead to worse outcomes. One of the main innovative trends currently is the use of molecular and functional methods to diagnosis. Numerous liver-specific contrast agents have been developed and studied in recent years to improve the performance of liver magnetic resonance imaging (MRI). More recently, one of the contrast agents introduced in clinical practice is gadoxetic acid (gadoxetate disodium).